GMPPB and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan: Moreover, the spectrum of glycosylation abnormalities has been increased with the report that GMPPB mutations can cause CMS, thus bridging myasthenic disorders with dystroglycanopathies.